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EDITORIAL COMMENT
Hypertrophic Cardiomyopathy
and Diastolic Dysfunction*
Pravin M. Shah, MD, MACC
Newport Beach, California
Hypertrophic cardiomyopathy (HCM) is a disease state
with characteristic pathologic changes most likely to result
in abnormalities of diastolic function. Indeed, HCM may
well be considered a “poster child” for diastolic dysfunction,
because pronounced ventricular hypertrophy is associated
with a reduced left ventricular (LV) cavity. The pressure-
volume relationship would almost certainly be shifted,
resulting in a steeper rise in pressure for a given increase in
filling volume. The symptoms in nonobstructive HCM
cases are generally attributed to abnormal diastolic function.
It has proved far more difficult to measure diastolic function
than to conceptualize it.
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Normal diastolic function may be defined in terms of
pressure-volume relationship, such that physiologic varia-
tions in filling are not associated with elevated end-diastolic
or filling pressures. Although it is technically possible to
continuously measure high-fidelity pressures and intracavi-
tary volumes using specialized invasive approaches, their use
is limited to investigational studies in few laboratories.
Hence, noninvasive measures of diastolic function are nec-
essary for applications in mainstream clinical settings.
Ventricular diastole as defined by Wiggers is composed of
isovolumic relaxation phase, rapid filling phase, diastasis,
and atrial systolic filling period. These time periods are
based on timing of rates and mechanisms of ventricular
filling. These are influenced by complex muscle mechanics
that include active myofiber relaxation (or lengthening),
elastic recoil, atrial filling pressures at moment of atrioven-
tricular valve opening (i.e., atrial “V” wave), myocardial
stiffness, and force and timing of atrial contraction. Thus,
conventional spectral Doppler parameters of diastolic filling
function based on mitral valve inflow velocity patterns,
described in terms of “impaired relaxation pattern,” “pseudo
normal filling pattern,” and “restrictive pattern” are too
simplistic and subject to a number of physiologic or func-
tional influences. For example, impaired relaxation pattern
of mitral inflow observed in association with increased
myocardial stiffness, such as hypertrophy or infiltration or
replacement fibrosis, is also influenced by rate of active
relaxation and by magnitude of atrial pressure (i.e., atrial
pressure-volume relationship). The so-called restrictive pat-
tern is indicative of high left atrial (LA) pressures and
should be better designated as “high filling pressure pat-
tern.” The pulmonary venous flow pattern has been used as
a rough gauge of LA pressure. These noninvasive estimates
of LA pressures are shown to be accurate only in presence of
depressed LV systolic function. Nishimura et al. (1) have
reported that mitral flow velocity curves cannot be used
reliably to reflect filling pressures in patients with HCM.
Furthermore, attempts to correlate exercise capacity with
Doppler indices of diastolic function have not been success-
ful (2–5). Tissue Doppler imaging (TDI) of mitral annulus
motion with the transducer placed at the apex has also been
proposed as a load-independent parameter of diastolic
function. In clinical practice, the velocity of annular motion
in one dimension obtained from the apex, although useful,
is not consistently reliable.
In this issue of the Journal, Kato et al. (6) report an
approach to directly measure myocardial velocity gradient
(MVG), defined as the difference in myocardial velocity
between the endocardium and the epicardium divided by
wall thickness. This measure of diastolic thinning was first
reported by Fleming et al. (7) in 1994 as being somewhat
insensitive to preload or atrial filling pressures. The present
report compares hemodynamic parameters obtained with
high-fidelity pressure recordings, traditional Doppler pa-
rameters of filling, and peak negative MVG in 36 patients
with nonobstructive HCM with 26 age-matched controls
studied for atypical chest pain and found to be free from
disease (i.e., normal subjects). The peak negative MVG
coincided with the initial phase of early filling, was signif-
icantly reduced in HCM, and was inversely correlated with
LV end-diastolic pressure, pulmonary artery wedge pres-
sure, and tau. The authors conclude that peak negative
MVG is a novel indicator of auxotonic relaxation, which
follows isovolumic relaxation, with filling occurring at vari-
able ventricular pressures. They suggest that this index
should prove useful in predicting diastolic dysfunction
characterized by increased stiffness and prolonged active
relaxation.
There are a few concerns with these conclusions. The
initial phase of filling is influenced by active relaxation,
elastic recoil, myocardial stiffness, and LA pressure at the
time of mitral valve opening (i.e., preload). Because the peak
negative MVG correlated with preload (i.e., pulmonary
artery wedge pressure), it is unlikely to be independent of
preload. Furthermore, because active relaxation and myo-
cardial stiffness are subject to variable influences, peak
negative MVG cannot be viewed as a “pure” measure of
diastolic function. Active relaxation may be influenced by
heart rate, catecholamines, and autonomic influences in
addition to underlying hypertrophy or ischemia. Thus, it is
unlikely that this measure would provide a purer or more
accurate assessment of diastolic dysfunction in HCM.
Further studies are needed to test if alterations in preload,
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heart rate, or catecholamines affect this measure. It appears
that a search for a reliable and “pure” noninvasive index of
LV diastolic function as exemplified by a steep pressure-
volume relationship must continue. In the meanwhile, peak
negative MVG may serve as a parameter in the clinical study
of diastole, in addition to mitral inflow velocities, pulmo-
nary venous flow velocities, and TDI of the mitral annulus.
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